logo

Royality Med Pharmaceuticals

Royality Med's mission is to fast-track the early stage of drug discovery using our predictive models of the human brain for therapeutic success. Many neurodevelopmental diseases do not have treatments due to a lack of a-priori knowledge of the underlying biology. Royality Med's technology is able to model these diseases to help enable the discovery of new targets and drugs, de-risking the current failure-prone cumbersome approach.
For inquiries, please contact us at
E-mail: info@royalitymed.com
mobile-logo
 

Pipeline & Products

The Journey Toward Regenerative Medicine Has Already Begun:



At Royality Med's Pharma, we know that no two fields are alike, and that farmers need solutions that will work in tandem to address their challenges and optimize their yields. That’s why we focus on creating innovations that are flexible enough for each grower’s needs and can work as systems that can be fine-tuned to the unique needs of their fields—from high-performing seeds at planting to the crop protection and digital tools they use to manage their fields every day.

With our industry-leading investment in research & development and a commitment to delivering digitally enabled tools to meet the individual needs of growers around the globe, we’re poised to bring cutting-edge technologies and next-generation solutions to life.

Regenerative agriculture starts with a commitment to innovation. Our R&D priorities are driven by farmers’ needs for integrated, effective solutions that help them combat crop threats and maximize productivity, all while reducing environmental impact and optimizing farm productivity around the world.





Biological Breakthroughs:



Not long-ago biological options were thought of only as microbials, but the reality is that the biologicals industry is expanding rapidly in many different directions. This includes new kinds of nature-derived biocontrol and biostimulant solutions like pheromone products, botanicals and plant extracts, and even synthetic biology.

Biologicals offer paths to new solutions, such as using synthetic biology to bring nitrogen fixing microbes to corn, wheat, or rice – food security crops that do not currently fix nitrogen from the air, but one day could.

Royality Med's Pharma is already shaping and growing the biologics segment as the preferred R&D development and commercial partner. We are positioned to build on our trusted brand, regulatory expertise, and global commercialization capabilities to bring new products to market more quickly. Partners who would otherwise only be able to impact thousands of growers alone, will be able to reach millions of growers with Royality Med's Pharma.




Digital and Carbon Frontiers:



Digital tools and data have been transforming agriculture for decades. The early promise of analytics and software tools in labs and greenhouses helped us to find genetic markers hidden among millions of bytes of data. Then new and effective digital tools moved on farm with FieldView, and we developed new ways for growers to make decisions about their farm armed with data far beyond what the eye can see.

But there’s a new frontier being explored right now. What started in the labs as a tool to build best-in-class seeds and traits, and then grew to the farm where it provided actionable insights, is now being transformed again – going beyond the farm and into the value chain.

Agriculture is a complex industry, and we’ve all spent the last 20+ years figuring out ways to create and formalize data. We’re now in an age of digitization where creating and leveraging useful data to provide advice, build confidence, and help growers share in the value chain is the name of the game.



A Customer Driven Precision Breeding Pipeline:



Precision Breeding will accelerate the development of new products while making them far more tailored to our customers’ fields and needs.

We’re not just using these tools to quantify customer preference, but also to combine those insights with multi-level data sets, and deep genomic understanding of our germplasm so that we can anticipate desired characteristics for our next-generation corn hybrids.

With precision breeding capabilities, we expect to reduce one breeding cycle from 6 years to 4 months – more than doubling our rate of genetic gain by 2030. This approach represents one of the most transformational changes in the history of plant breeding.



Transformative Traits



Royality Med's Pharma Crop Science is the undisputed leader of plant biotechnology. We have launched more biotech traits than any other company, enabling farmers to grow crops like corn, soybeans, cotton, and canola with game-changing capabilities on around 300 million acres annually.

Through expertise in four key technologies – gene, protein, RNA, and genome – Royality Med's Pharma replenishes and improves our trait offerings and biotech pipeline; even creating the largest multi-gene stacks for growers.




I would like to learn about Royality Med’s Pharmaceuticals discoveries to treat genetic diseases.


YES, TELL ME MORE